Ignite Creation Date:
2024-05-05 @ 9:33 PM
Last Modification Date:
2024-10-26 @ 10:06 AM
Study NCT ID:
NCT00913510
Status:
TERMINATED
Last Update Posted:
2021-11-11
First Post:
2009-06-03
Brief Title:
Efficacy of Clean Intermittent Catheterization CIC in Multiple Sclerosis MS Patients With Bladder Dysfunction
Sponsor:
Wellspect HealthCare
Organization:
Wellspect HealthCare
Study Overview
Official Title:
Efficacy of Clean Intermittent Self-catheterization in Combination With Anticholinergic Drugs for Treatment of Bladder Dysfunction in Multiple Sclerosis
Status:
TERMINATED
Status Verified Date:
2014-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aims of this prospective randomized study are
To assess the effect of clean intermittent catheterization CIC
To investigate if MS patients will have symptom reduction urgency frequency nocturia and incontinence when using CIC in combination with anticholinergic drugs
To identify at what volume of Postvoid Residual PVR urine starting CIC improves bladder control and QoL
To increase the evidence of CIC and support clinical guidelines of bladder management in MS patients
To assess the effect of clean intermittent catheterization CIC
To investigate if MS patients will have symptom reduction urgency frequency nocturia and incontinence when using CIC in combination with anticholinergic drugs
To identify at what volume of Postvoid Residual PVR urine starting CIC improves bladder control and QoL
To increase the evidence of CIC and support clinical guidelines of bladder management in MS patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None